The impact of sex hormones on one-session cognitive therapy for women with spider phobia. .

Not Applicable

Completed

• Conditions: Anxiety; Spider phobia; Mental Health - Anxiety

• Registration Number: ACTRN12616001525471
• Lead Sponsor: The University of New South Walkes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Naturally cycling women with spider phobia, aged 18-35

Exclusion Criteria

Pregnant, breastfeeding, using hormonal contraceptives, irregular menstrual cycles, endocrinology disorders, psychosis, physical conditions that may be exacerbated by stress (asthma, heart disease)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change from baseline in the level of approach on the Behavioural Approach Task (BAT)[Pre-treatment, 1-week and 13-weeks post-treatment]

Secondary Outcome Measures

Name	Time	Method
Change from baseline in severity of spider phobia on the Spider Phobia Questionnaire[Pre-treatment, and 1 week and 13 weeks post treatment];Change from baseline in diagnostic criteria meet for specific phobia on the Diagnostic Assessment. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) will be used as the diagnostic criteria.[Pre-treatment, and 1 week and 12 weeks post treatment];Self-reported conviction rating (i.e., as a percentage, how likely it is that the feared outcome will occur)[Pre-treatment, and 1 week and 12 weeks post treatment]